Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784)
08/2012
08/02/2012US20120195932 Geodate delivery vehicles
08/02/2012US20120195927 Gm-negative ehv-mutants without heterologous elements
08/02/2012US20120195926 Methods of improving vaccine immunogenicity
08/02/2012US20120195925 Vaccines with increased immunogenicity and methods for obtaining them
08/02/2012US20120195922 Methods for preparing complex multivalent immunogenic conjugates
08/02/2012US20120195920 Staphylococcus aureus div1b for use as vaccine
08/02/2012US20120195919 Hybrid and tandem expression of neisserial proteins
08/02/2012US20120195911 Method of treatment of cancer patients
08/02/2012US20120195907 Monoclonal antibodies against the pbp2-a protein and homologous sequences for the treatment of infections by and immunodiagnostics of bacteria of the firmicutes phylum
08/02/2012US20120195904 METHOD TO TREAT USING ANTAGONISTIC ANTI-hTNFSF13B HUMAN ANTIBODIES
08/02/2012US20120195899 Immunizing Compositions and Methods of Use
08/02/2012US20120195898 Immunizing Compositions and Methods of Use
08/02/2012US20120195894 Regulatory t cell mediator proteins and uses thereof
08/02/2012US20120195893 TH1/TH2 polarizing vaccines
08/02/2012US20120195891 Methods, compositions, and kits for treating shiga toxin associated conditions
08/02/2012US20120195881 Pentafluorosulfur imino heterocyclic compounds as bace-1 inhibitors, compositions and their use
08/02/2012US20120195875 Detection of immune modulation resulting from reduced protein phosphatase 2a activity
08/02/2012US20120195872 Antimicrobial agents
08/02/2012US20120195857 Hepatitis C Virus Inhibitors
08/02/2012US20120195852 Vaccines, immunotherapeutics and methods for using the same
08/02/2012US20120195838 Oral composition for denture wearers
08/02/2012US20120195836 Foamable Iodine Compositions
08/02/2012US20120195832 Process for producing an injectable medicament preparation
08/02/2012US20120195826 Injectable biomaterial
08/02/2012DE102011009961A1 7-Azaindolderivate 7-azaindole derivatives
08/02/2012DE102011003478A1 Antivirales Mittel enthaltend rekombinante Mistellektine An antiviral agent containing recombinant mistletoe lectins
08/02/2012CA2825889A1 Topical antifungal agent
08/02/2012CA2825403A1 Combination vaccines
08/01/2012EP2481739A1 Dihydropteridinone derivatives, preparation process and pharmaceutical use thereof
08/01/2012EP2481738A1 Maleic acid salt and crystal thereof
08/01/2012EP2481735A1 Substituted heterocyclic derivatives and compositions and their pharmaceutical use as antibacterials
08/01/2012EP2481723A2 Substituted tetracycline compounds
08/01/2012EP2481425A1 Toll like receptor 3 antagonists, methods and uses
08/01/2012EP2481419A2 Neisserial vaccines
08/01/2012EP2481401A1 Lipophilic microparticles containing a protein drug or antigen and formulation comprising same
08/01/2012EP2480556A1 Heterocyclic antiviral compounds
08/01/2012EP2480549A1 Fused imidazo [3, 2 - d]pyrazines as pi3 kinase inhibitors
08/01/2012EP2480533A1 Heterocyclic antiviral compounds
08/01/2012EP2480241A1 Bacterial spore having therapeutic agent adsorbed on its surface
08/01/2012EP2480236A1 Compositions and methods for treating bacterial infections using ceftaroline
08/01/2012EP2480229A2 Zinc-containing compositions for the treatment of diseases, illnesses and syndromes associated with exposure to pore forming toxins
08/01/2012EP2480226A2 Composition comprising s-allyl-l-cysteine as active ingredient for preventing or treating gastrointestinal disorders
08/01/2012EP2480220A2 Treatment and prevention of hiv infection
08/01/2012EP2480074A1 Contact lens disinfecting solutions
08/01/2012EP2188016B1 Use of octreotide as a therapeutic agent
08/01/2012EP2159224B1 Bromo-phenyl substituted thiazolyl dihydropyrimidines
08/01/2012EP1812023B1 Lactic acid bacteria as probiotic strains and compositions containing same
08/01/2012EP1799663B1 Modulators of HCV replication
08/01/2012EP1633395B1 Functionally reconstituted viral membranes containing adjuvant
08/01/2012EP1585757B1 Peptide deformylase inhibitors
08/01/2012EP1389120B1 Use of nystatin for the treatment of atherosclerosis linked to the presence of parasitic fungi
08/01/2012EP1181057B1 Noninvasive genetic immunization, expression products therefrom, and uses thereof
08/01/2012CN102625813A Immunoglobulins with reduced aggregation
08/01/2012CN102625804A Compounds useful for treating AIDS
08/01/2012CN102625800A Benzyl aralkyl ether compounds, method for preparing same, intermediate compounds, use of said compounds, method for treatment and/or prevention, pharmaceutical composition and medicament containing same
08/01/2012CN102621243A Fingerprint spectrum of henbane medicinal material and method for controlling quality of henbane medicinal material
08/01/2012CN102618557A Recombinant avian flavivirus E protein and application thereof
08/01/2012CN102618541A Compositions for treating respiratory viral infections and their use
08/01/2012CN102618508A Recombinant porcine pseudorabies virus, as well as construction method and application thereof
08/01/2012CN102618504A Bivalent vaccine for hemorrhagic fever with renal syndrome and its preparation method
08/01/2012CN102618503A Hybrid tumor cell strain 1D7 capable of secreting high neutralizing activity canine distemper virus monoclonal antibody
08/01/2012CN102618453A Apx I C gene deleted mutant strain of porcine infectious actinobacillus pleuropneumonia, construction method, vaccine and application
08/01/2012CN102618415A Process for preparing chestnut flower wine
08/01/2012CN102618386A Method for preparing chenopodium vulvaria volatile oil and application of chenopodium vulvaria volatile oil
08/01/2012CN102617739A Novel method for preventing or treating M tuberculosis infection
08/01/2012CN102617738A Polypeptides, coding sequences, preparation method and use of recombinant fusion protein CD4-LINKER-DC-SIGN (CLD)
08/01/2012CN102617736A The new stable polyethylene glycol conjugate of interferon alpha, represented by one positional isomer
08/01/2012CN102617733A Antibodies directed against amyloid-beta peptide and methods using same
08/01/2012CN102617731A Porcine circovirus-resistant type 2 egg yolk antibody, and preparation method and application thereof
08/01/2012CN102617724A Swine alexin pBD1 polypeptide and application thereof to inhibition of swine pathogenetic fungi
08/01/2012CN102617712A Polypeptide for effectively restraining activity of influenza virus polymerase
08/01/2012CN102617705A Macrocyclic compound for suppressing replication of hepatitis c viruses
08/01/2012CN102617632A Organic germanium complex, and preparation method and application thereof
08/01/2012CN102617621A Fluorescent antibacterial rare earth ternary complexes, and preparation method and application thereof
08/01/2012CN102617620A Heterocyclic ligand-containing efficiently-antibacterial rare earth ternary complexes, and preparation method and application thereof
08/01/2012CN102617613A High-efficiency antibacterial copper ternary complex containing heterocyclic ligand, and preparation method and application thereof
08/01/2012CN102617612A Biapenem B-type crystallinity
08/01/2012CN102617607A Method for preparing cefazolin compounds
08/01/2012CN102617606A Method for preparing ceftezole sodium compound
08/01/2012CN102617605A Ceftriaxone sodium compound and preparation method thereof
08/01/2012CN102617595A Preparation method of fluoroquinolone antibacterial medicament marbofloxacin
08/01/2012CN102617571A Novel pyridazine compound and use thereof
08/01/2012CN102617562A Thiazole derivant and preparation method and use thereof
08/01/2012CN102617561A 2-benzylthio benzene heterocyclic-fused derivative, preparation method thereof and medical application thereof
08/01/2012CN102617536A Isoflavone compound, its preparation method, and its application in preparation of antiviral or antitumor drugs
08/01/2012CN102617494A Triazole compounds containing olefine ether structure, and preparation method and application thereof
08/01/2012CN102617491A 3-oxo-3,4-dihydro-2-pyrazinecarboxamide derivative, medicinal composition thereof and preparation method and application of 3-oxo-3,4-dihydro-2-pyrazinecarboxamide derivative
08/01/2012CN102617487A Multi-substituted pyrimidinones compounds as well as preparation method and application thereof
08/01/2012CN102617443A Optically active indole derivative, synthetic method and application thereof
08/01/2012CN102614526A Cross-protection DNA vaccine
08/01/2012CN102614523A Dexamethasone macromolecule prodrug and preparation method thereof
08/01/2012CN102614512A Multiple-variable dose regimen for treating TNFalpha-related disorders
08/01/2012CN102614511A Propolis-adjuvant inactivated vaccine for mink pasteurellosis
08/01/2012CN102614510A Yeast-based therapeutic for chronic hepatitis C infection
08/01/2012CN102614509A Preparation method of orally-taken vaccine for treatment of hemorrhage of grass carp
08/01/2012CN102614508A Virus split deactivation method for human influenza virus split vaccine
08/01/2012CN102614507A Type O foot-and-mouth disease virus molecular marker vaccine and preparation method thereof
08/01/2012CN102614506A Recombinant HPV16L2 protein vaccine and preparation method thereof
08/01/2012CN102614505A Chimeric protein vaccine containing HPV16 type L1 and E7 target antigens expressed in yeast cells and its preparation method
08/01/2012CN102614504A Pseudomonas fluorescens recombinant protein vaccine and preparation method thereof
1 ... 257 258 259 260 261 262 263 264 265 266 267 268 269 270 271 272 273 274 275 276 277 ... 1798